Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: Lack of any association in a case-control study

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 3101-3104

  Akkiz, Hikmet ^a   Bayram, Süleyman ^b   Bekar, Aynur ^a   Akgöllü, Ersin ^a   Üsküdar, Oǧuz ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

Author keywords

HCC; MicroRNA 499; Rs3746444 A G Polymorphism; Susceptibility; Turkey

Indexed keywords

EID: 84863315185     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Akkiz H, Bayram S, Bekar A, Akgöllü E, Ozdil B (2010). Relationship between functional polymorphism in the Aurora A gene and susceptibility of hepatocellular carcinoma. J Viral Hepat, 17, 668-74.
2. Akkiz H, Bayram S, Bekar A, Akgöllü E, Ulger Y (2011). A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat, 18, e399-407.
3. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
4. Bruix J, Sherman M, Llovet JM, et al(2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 35, 421-30.
5. Catucci I, Yang R, Verderio P, et al(2010). Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat, 31, E1052-7.
6. Duan R, Pak C, Jin P (2007). Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet, 16, 1124-31.
7. Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with role in cancer. Nat Rev Cancer, 6, 259-69.
8. George GP, Gangwar R, Mandal RK, Sankhwar SN, Mittal RD (2011). Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol Biol Rep, 38, 1609-15.
9. Hu Z, Chen J, Tian T, et al(2008). Genetic variants of miRNA sequences and non small cell lung cancer survival. J Clin Invest, 118, 2600-8.
10. Hu Z, Liang J, Wang Z, et al(2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat, 30, 79-84.
11. Hu Z, Chen X, Zhao Y, et al(2010). Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol, 28, 1721-6.
12. Huang S, He X (2011). The role of microRNAs in liver cancer progression. Br J Cancer, 104, 235-40.
13. Jemal A, Bray F, Center MM, et al(2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
14. Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN (2009). Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim Biophys Acta, 1792, 341-52.
15. Liu Z, Li G, Wei S, et al(2010). Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer, 116, 4753-60.
16. Lodato F, Mazzella G, Festi D, et al(2006). Hepatocellular carcinoma prevention: aworldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol, 12, 7239-49.
17. Loktionov A (2004). Common gene polymorphisms, cancer progression and prognosis. Cancer Lett, 208, 1-33.
18. Lovet JM, Fuster J, Bruix J (2004). The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl, 10, S115-20.
19. Ludwig JA, Weinstein JN (2005). Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer, 5, 845-56.
20. Mittal RD, Gangwar R, George GP, Mittal T, Kapoor R (2011). Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA Cell Biol, 30, 401-6.
21. NCBI dbSNP CEU HapMap Phase 3 (2011) www.ncbi.nlm.nih.gov/projects/SNP/dbSNP
22. Okubo M, Tahara T, Shibata T, et al (2010). Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter, 15, 524-31.
23. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973). Transection of the esophagus for bleeding esophageal varices. Br J Surg, 60, 646-9.
24. Srivastava K, Srivastava A, Mittal B (2010). Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet, 55, 495-9.
25. The microRNA Database (2011). http://www.mirbase.org/
26. Tian T, Shu Y, Chen J, et al(2009). A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev, 18, 1183-7.
27. Tsai JF, Chang WY, Jeng JE, et al(1994). Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver, 14, 98-102.
28. Vasudevan S, Tong Y, Steitz JA (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science, 318, 1931-4.
29. Wang JX, Jiao JQ, Li Q, et al(2011). miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med, 17, 71-8.
30. Zeng Y, Cullen BR (2003). Sequence requirements for micro RNA processing and function in human cells. RNA, 9, 112-23.
31. Zhou B, Wang K, Wang Y, et al(2011). Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog, 50, 499-505.
32. Zhou J, Lv R, Song X, et al(2011) Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol, (Epub ahead of print).